Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy processing market from 2025–2034 with trusted insights from The Business Research Company
What Is The Predicted Market Size Of The Cell Therapy Processing Industry By 2029?
The cell therapy processing market has seen significant expansion in recent years. It is projected to grow from $4.54 billion in 2024 to $5.18 billion in 2025, with a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to factors such as the increasing adoption of cell-based therapies, rising investment in biomanufacturing infrastructure, growing demand for personalized medicine, enhanced clinical success of cell therapies, and the escalating requirement for good manufacturing practices (GMP)-compliant processing systems.
The cell therapy processing market is poised for significant expansion in the coming years, with its value projected to reach $8.73 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.9%. This anticipated growth is driven by several factors, including a heightened emphasis on automated cell processing technologies, the growing incorporation of artificial intelligence (AI) into cell manufacturing workflows, an increasing need for scalable allogeneic cell therapies, greater regulatory encouragement for advanced therapy production, and a surge in collaborations between biotechnology companies and contract development and manufacturing organization (CDMOs). Key trends expected during this period involve progress in closed-system bioreactor technologies, the creation of real-time monitoring tools for cell cultures, novel approaches in cryopreservation and cell storage methods, improvements in cell separation and purification techniques, and the establishment of modular and scalable good manufacturing practices (GMP) manufacturing platforms.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp
Which Industry Forces Are Driving The Cell Therapy Processing Market Forward?
The increasing volume of cell therapy research is projected to stimulate the expansion of the cell therapy processing market moving forward. Cell therapy describes the procedure of producing therapeutic items derived from living cells to treat or manage a range of diseases, including cancers, autoimmune conditions, and genetic ailments. The need for cell-based therapy is escalating due to a rising requirement for scalable and consistent manufacturing platforms that can accommodate high cell densities without compromising the quality of the product. Cell therapy processing proves beneficial for cell therapy research because it enables the standardized preparation, quality control, and scalable production of premium cells, thus ensuring reliable and reproducible outcomes for both experimental and clinical studies. For example, in December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit body, indicated that six first-in-class cell and gene treatments were rolled out in 2023, which is 50% more than the three introduced in 2022. Therefore, the growing number of cell therapy research activities is a key factor driving the growth of the cell therapy processing market.
What Is The Segment Breakdown Of The Cell Therapy Processing Market?
The cell therapy processing market covered in this report is segmented
1) By Offering Type: Products, Services, Software
2) By Applications: Cardiovascular Devices, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications
3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users
Subsegments:
1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents
2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services
3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software
How Are Global Trends Impacting The Development Of The Cell Therapy Processing Market?
Major entities active in the cell therapy processing market are prioritizing the creation of sophisticated solutions, including integrated bioreactor-centrifuge systems, to enhance manufacturing workflows and boost the uniformity, expandability, and sterility of cell-based treatments. An integrated bioreactor-centrifuge system functions as a consolidated apparatus that merges cell incubation and centrifugal separation within a solitary, sealed unit, allowing for continuous, automated cell processing devoid of intermediate transfers. Illustratively, in March 2025, Limula SA, a Switzerland-based company known for cell and gene therapy (CGT) production, unveiled LimONE, an automated, closed-system platform dedicated to cell therapy manufacturing. The innovative system integrates hardware, single-use consumables, and software guided by protocols to consolidate intricate cell processing stages, such as incubation, centrifugation, and reagent handling, into a single compact unit. This facilitates the consistent, scalable production of therapies like CAR-T and gene-edited stem cells, from research phases to GMP-compliant manufacturing, eliminating the necessity for complex technology transfers.
Which Companies Are Contributing Significantly To The Cell Therapy Processing Market Growth?
Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Nkarta Inc., Cellares Corporation, Cellectis S.A., JW (Cayman) Therapeutics Company Limited, Cell Therapies Pty Ltd., and InGeneron Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report
Which Region Is Leading Innovation In The Cell Therapy Processing Market?
North America was the largest region in the cell therapy processing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp
Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2025, By The Business Research Company
Metal Structural Insulation Panels Global Market Report 2025
Structural Insulated Panels Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market
Vacuum Insulation Panel Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
